MiRNA-7-5p inhibits melanoma cell migration and invasion

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 706-710

  Giles, Keith M ^a   Brown, Rikki A M ^a   Epis, Michael R ^a   Kalinowski, Felicity C ^a   Leedman, Peter J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Invasion; Melanoma; Metastasis; MicroRNA; Migration; Signaling

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 2; MICRORNA; MICRORNA 7 5P; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; MELANOMA CELL; METASTATIC MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MELANOMA; MICRORNAS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84872323522     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.086     Document Type: Article

References (35)

1. K.T. Flaherty, Targeting metastatic melanoma, in: C.T. Caskey, C.P. Austin, J.A. Hoxie (Eds.), Annual Reviews, Palo Alto, U.S.A., Annu. Rev. Med. 63 (2012) 171-183.
2. Sosman J.A., Kim K.B., Schuchter L., Gonzalez R., Pavlick A.C., Weber J.S., McArthur G.A., Hutson T.E., Moschos S.J., Flaherty K.T., Hersey P., Kefford R., Lawrence D., Puzanov I., Lewis K.D., Amaravadi R.K., Chmielowski B., Lawrence H.J., Shyr Y., Ye F., Li J., Nolop K.B., Lee R.J., Joe A.K., Ribas A. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N. Engl. J. Med. 2012, 366:707-714.
3. Wagle N., Emery C., Berger M.F., Davis M.J., Sawyer A., Pochanard P., Kehoe S.M., Johannessen C.M., MacConaill L.E., Hahn W.C., Meyerson M., Garraway L.A. Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J. Clin. Oncol. 2011, 29:3085-3096.
4. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79:351-379.
5. Bonazzi V.F., Stark M.S., Hayward N.K. MicroRNA regulation of melanoma progression. Melanoma Res. 2012, 22:101-113.
6. White N.M.A., Fatoohi E., Metias M., Jung K., Stephan C., Yousef G.M. Metastamirs: a stepping stone towards improved cancer management. Nat. Rev. Clin. Oncol. 2011, 8:75-84.
7. Segura M.F., Greenwald H.S., Hanniford D., Osman I., Hernando E. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis 2012, 33:1823-1832.
8. Migliore C., Petrelli A., Ghiso E., Corso S., Capparuccia L., Eramo A., Comoglio P.M., Giordano S. MicroRNAs impair MET-mediated invasive growth. Cancer Res. 2008, 68:10128-10136.
9. M. Garofalo, C.M. Croce, MicroRNAs: master regulators as potential therapeutics in cancer, in: A.K. Cho (Ed.), Annual Reviews, Palo Alto, Annu. Rev. Pharmacol. Toxicol. 51 (2011) 25-43.
10. Reddy S.D.N., Ohshiro K., Rayala S.K., Kumar R. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res. 2008, 68:8195-8200.
11. Kefas B., Godlewski J., Comeau L., Li Y., Abounader R., Hawkinson M., Lee J., Fine H., Chiocca E.A., Lawler S., Purow B. MicroRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 2008, 68:3566-3572.
12. Jiang L., Liu X., Chen Z., Jin Y., Heidbreder C.E., Kolokythas A., Wang A., Dai Y., Zhou X. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem. J. 2010, 432:199-205.
13. Wu D., Wang Y., Fan L., Luo H., Han B., Sun L., Wang X., Zhang J., Cao L., Wang X., You Y., Liu N. MicroRNA-7 regulated glioblastoma cell invasion via targeting focal adhesion kinase expression. Chin. Med. J. 2011, 124:2616-2621.
14. Pogribny I.P., Filkowski J.N., Tryndyak V.P., Golubov A., Shpyleva S.I., Kovalchuk O. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int. J. Cancer 2010, 127:1785-1794.
15. Kalinowski F.C., Giles K.M., Candy P.A., Ali A., Ganda C., Epis M.R., Webster R.J., Leedman P.J. Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7. PLoS ONE 2012, 7:e47067.
16. Philippidou D., Schmitt M., Moser D., Margue C., Nazarov P.V., Muller A., Vallar L., Nashan D., Behrmann I., Kreis S. Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer Res. 2010, 70:4163-4173.
17. Mueller D.W., Bosserhoff A.K. Role of miRNAs in the progression of malignant melanoma. Br. J. Cancer 2009, 101:551-556.
18. Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., Parks W.P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. 1973, 51:1417-1423.
19. Herlyn M., Balaban G., Bennicelli J., Guerry D., Halaban R., Herlyn D., Elder D.E., Maul G.G., Steplewski Z., Nowell P.C., Clark W.H., Koprowski H. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J. Natl. Cancer Inst. 1985, 74:283-289.
20. Fabricant R.N., De Larco J.E., Todaro G.J. Nerve growth factor receptors on human melanoma cells in culture. Proc. Nat. Acad. Sci. U.S.A. 1977, 74:565-569.
21. Wang X., Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res. 2003, 31:e154.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001, 25:402-408.
23. Giles K., Barker A., Zhang P.M., Epis M.R., Leedman P.J. MicroRNA regulation of growth factor receptor signaling in human cancer cells. Methods Mol. Biol. 2011, 676:147-163.
24. Limame R., Wouters A., Pauwels B., Fransen E., Peeters M., Lardon F., De Wever O., Pauwels P. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS ONE 2012, 7:e46536.
25. Kong X., Li G., Yuan Y., He Y., Wu X., Zhang W., Wu Z., Chen T., Wu W., Lobie P.E., Zhu T. MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PLoS ONE 2012, 7:e41523.
26. Zhao X., Dou W., He L., Liang S., Tie J., Liu C., Li T., Lu Y., Mo P., Shi Y., Wu K., Nie Y., Fan D. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 2012.
27. Fang Y.X., Xue J.-L., Shen Q., Chen J., Tian L. miR-7 inhibits tumor growth and metastasis by targeting the PI3K/AKT pathway in hepatocellular carcinoma. Hepatology 2012, [Epub ahead of print]. 10.1002/hep.25576.
28. Webster R.J., Giles K.M., Price K.J., Zhang P.M., Mattick J.S., Leedman P.J. Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J. Biol. Chem. 2009, 284:5731-5741.
29. Saydam O., Senol O., Würdinger T., Mizrak A., Ozdener G.B., Stemmer-Rachamimov A.O., Yi M., Stephens R.M., Krichevsky A.M., Saydam N., Brenner G.J., Breakefield X.O. MiRNA-7 attenuation in schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res. 2011, 71:852-861.
30. Marshall J.-C., Nantel A., Blanco P., Ash J., Cruess S., Burnier M. Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis. Clin. Exp. Metastasis 2007, 24:353-362.
31. Mardilovich K., Pankratz S., Shaw L. Expression and function of the insulin receptor substrate proteins in cancer. Cell. Signal. 2009, 7:14.
32. Shaw L.M. Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the α6β4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol. Cell. Biol. 2001, 21:5082-5093.
33. Shivdasani R.A. MicroRNAs: regulators of gene expression and cell differentiation. Blood 2006, 108:3646-3653.
34. Madhunapantula S.V., Robertson G.P. Therapeutic implications of targeting Akt signaling in melanoma. Enzyme Res. 2011, 2011:1-20.
35. Bader A.G., Brown D., Winkler M. The promise of microRNA replacement therapy. Cancer Res. 2010, 70:7027-7030.